Shuyuan Wang
Beijing, 100191, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Druggability Studies of Benzene Sulfonamide Substituted Diarylamide (E3) as a Novel Diuretic.
Journal: Biomedicines
Published: March 20, 2025
Aquaporin Inhibitors.
Journal: Advances in experimental medicine and biology
Published: January 30, 2023
Urea Transporter Inhibitor 25a Reduces Ascites in Cirrhotic Rats.
Journal: Biomedicines
Published: December 22, 2022
Dapagliflozin protects against nonalcoholic steatohepatitis in db/db mice.
Journal: Frontiers in pharmacology
Published: May 12, 2022
Preclinical Pharmacokinetic Studies of a Novel Diuretic Inhibiting Urea Transporters.
Journal: Molecules (Basel, Switzerland)
Published: March 13, 2022
An HPLC-MS/MS Method for Pharmacokinetic Study of Y-99: A Novel Diuretic Agent Targeting Urea Transporters.
Journal: Journal of chromatographic science
Published: December 01, 2021
N-(4-acetamidophenyl)-5-acetylfuran-2-carboxamide as a novel orally available diuretic that targets urea transporters with improved PD and PK properties.
Journal: European journal of medicinal chemistry
Published: August 04, 2021
Inhibiting Focal Adhesion Kinase Ameliorates Cyst Development in Polycystin-1-Deficient Polycystic Kidney Disease in Animal Model.
Journal: Journal of the American Society of Nephrology : JASN
Published: November 03, 2020
Discovery of novel diarylamides as orally active diuretics targeting urea transporters.
Journal: Acta pharmaceutica Sinica. B
Published: March 26, 2020
Cardamonin retards progression of autosomal dominant polycystic kidney disease via inhibiting renal cyst growth and interstitial fibrosis.
Journal: Pharmacological research
Published: January 30, 2020
Showing 1-10 of 10
Last Updated: 09/26/2026